Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital ...

Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...